Valuation: DexCom, Inc.

Market Cap 32.69B 579B 28.68B 27.09B 24.69B 46.21B 3,133B 46.54B 324B 126B 1,601B 123B 120B 5,144B P/E 2026 *
34.7x
P/E 2027 * 29.2x
Enterprise Value 31.93B 566B 28.01B 26.46B 24.11B 45.14B 3,060B 45.46B 317B 123B 1,563B 120B 117B 5,024B EV / Sales 2026 *
6.1x
EV / Sales 2027 * 5.45x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+0.48%
1 week+0.48%
Current month+0.48%
1 month+0.48%
3 months+23.72%
6 months+27.00%
Current year+26.65%
1 week 1,536.29
Extreme 1536.29
1,536.29
1 month 1,536.29
Extreme 1536.29
1,536.29
Current year 1,064.65
Extreme 1064.65
1,556.82
1 year 1,062.55
Extreme 1062.55
1,556.82
3 years 1,062.55
Extreme 1062.55
2,260
5 years 1,062.55
Extreme 1062.55
3,366.38
10 years 212.78
Extreme 212.775
3,366.38
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%+0.48% - - 32.69B
+0.22%-1.29%-24.16%+6.03% 175B
+0.15%-3.79%-5.92%+13.32% 113B
-0.95%-0.60%-0.03%+65.76% 58.57B
+2.56%+1.59%-0.42%-28.97% 50.07B
+0.45%+1.94%+16.04%+55.40% 49.92B
-0.97%-3.06%+29.09%-5.94% 32.69B
+0.12%+9.67% - - 30.44B
-0.85%+2.24%+41.65%-1.26% 26.07B
+2.35%+7.74%+26.98%-1.63% 23.55B
Average +0.35%+1.76%+10.40%+12.84% 62.22B
Weighted average by Cap. +0.29%+0.01%-2.75%+14.10%

Financials

2026 *2027 *
Net sales 5.23B 92.71B 4.59B 4.33B 3.95B 7.39B 501B 7.45B 51.87B 20.09B 256B 19.64B 19.21B 823B 5.8B 103B 5.09B 4.81B 4.38B 8.2B 556B 8.26B 57.52B 22.28B 284B 21.78B 21.31B 913B
Net income 974M 17.27B 855M 808M 736M 1.38B 93.39B 1.39B 9.66B 3.74B 47.71B 3.66B 3.58B 153B 1.15B 20.37B 1.01B 952M 868M 1.62B 110B 1.64B 11.39B 4.41B 56.26B 4.31B 4.22B 181B
Net Debt -761M -13.49B -668M -631M -575M -1.08B -72.95B -1.08B -7.55B -2.92B -37.27B -2.86B -2.8B -120B -1.06B -18.82B -931M -880M -802M -1.5B -102B -1.51B -10.53B -4.08B -51.98B -3.99B -3.9B -167B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
86.62USD
Average target price
94.48USD
Spread / Average Target
+9.07%

Quarterly revenue - Rate of surprise